郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

肿瘤模型Enhancement of synthetic lethality via combinations of ABT-888, a PARP inhibitor, and carboplatin in vitro and in vivo using BRCA1 and BRCA2 isogenic models.

期刊:Molecular cancer therapeutics发表年份:2012作者:Caroline C Clark; Jeffrey N Weitzel; Timothy R O'Connor

肿瘤模型Interactions of bilastine, a new oral H₁ antihistamine, with human transporter systems.

期刊:Drug and chemical toxicology发表年份:2012作者:Maria Luisa Lucero; Ana Gonzalo; Alvaro Ganza; Nerea Leal; Itziar Soengas; Eniko Ioja; Szilvia Gedey; Mirza Jahic; Dallas Bednarczyk

肿瘤模型Akt acutely activates the cholesterogenic transcription factor SREBP-2.

期刊:Biochimica et biophysica acta发表年份:2012作者:Winnie Luu; Laura J Sharpe; Julian Stevenson; Andrew J Brown

肿瘤模型Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.

期刊:Biotechnology and bioengineering发表年份:2012作者:Ruben T Almaraz; Udayanath Aich; Hargun S Khanna; Elaine Tan; Rahul Bhattacharya; Shivam Shah; Kevin J Yarema